• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胶质细胞:帕金森病病理发生的启动子和进展者。

Glia: initiators and progressors of pathology in Parkinson's disease.

机构信息

Neuroscience Research Australia, Sydney, Australia.

出版信息

Mov Disord. 2011 Jan;26(1):6-17. doi: 10.1002/mds.23455.

DOI:10.1002/mds.23455
PMID:21322014
Abstract

BACKGROUND

Glia are traditionally known as support cells for neurons, and their role in neurodegeneration has been largely considered secondary to neuronal dysfunction. We review newer concepts on glial function and assess glial changes in Parkinson's disease (PD) at the time of disease initiation when α-synuclein is accumulating in brain tissue but there is limited neuronal loss, and also as the disease progresses and neuronal loss is evident.

RESULTS

Of the two main types of astrocytes, only protoplasmic astrocytes are involved in PD, where they become nonreactive and accumulate α-synuclein. Experimental evidence has shown that astrocytic α-synuclein deposition initiates the noncell autonomous killing of neurons through microglial signaling. As the disease progresses, more protoplasmic astrocytes are affected by the disease with an increasing microglial response. Although there is still controversy on the role microglia play in neurodegeneration, there is evidence that microglia are activated early in PD and possibly assist with the clearance of extracellular α-synuclein at this time. Microglia transform to phagocytes and target neurons as the disease progresses but appear to become dysfunctional with increasing amounts of ingested debris. Only nonmyelinating oligodendroglial cells are affected in PD, and only late in the disease process.

CONCLUSIONS

Glial cells are responsible for the progression of PD and play an important role in initiating the early tissue response. In particular, early dysfunction and α-synuclein accumulation in astrocytes causes recruitment of phagocytic microglia that attack selected neurons in restricted brain regions causing the clinical symptoms of PD.

摘要

背景

神经胶质细胞传统上被认为是神经元的支持细胞,其在神经退行性变中的作用在很大程度上被认为次于神经元功能障碍。我们综述了神经胶质细胞功能的新概念,并评估了在帕金森病(PD)发病时(当α-突触核蛋白在脑组织中积累但神经元丢失有限时)以及随着疾病进展和神经元丢失明显时的神经胶质变化。

结果

在两种主要类型的星形胶质细胞中,只有原浆型星形胶质细胞参与 PD,在 PD 中它们变得非反应性并积累α-突触核蛋白。实验证据表明,星形胶质细胞α-突触核蛋白沉积通过小胶质细胞信号引发非细胞自主的神经元杀伤。随着疾病的进展,更多的原浆型星形胶质细胞受到疾病的影响,小胶质细胞的反应也随之增加。尽管小胶质细胞在神经退行性变中的作用仍存在争议,但有证据表明小胶质细胞在 PD 早期被激活,并且可能在此时间协助清除细胞外α-突触核蛋白。小胶质细胞随着疾病的进展转变为吞噬细胞并靶向神经元,但随着摄入的碎片越来越多,它们似乎变得功能失调。只有非髓鞘形成的少突胶质细胞在 PD 中受到影响,而且仅在疾病后期。

结论

神经胶质细胞是 PD 进展的罪魁祸首,在引发早期组织反应中发挥着重要作用。特别是星形胶质细胞的早期功能障碍和α-突触核蛋白积累会招募吞噬性小胶质细胞,这些小胶质细胞攻击特定脑区的选定神经元,导致 PD 的临床症状。

相似文献

1
Glia: initiators and progressors of pathology in Parkinson's disease.胶质细胞:帕金森病病理发生的启动子和进展者。
Mov Disord. 2011 Jan;26(1):6-17. doi: 10.1002/mds.23455.
2
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.在帕金森病早期,α-突触核蛋白重新分布至黑质中的神经黑素脂质。
Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6.
3
Interaction between α-synuclein and tau in Parkinson's disease comment on Wills et al.: elevated tauopathy and α-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol 2010; 225: 210-218.帕金森病中α-突触核蛋白与tau 相互作用 评论 Wills 等人:痴呆和非痴呆帕金森病死后脑中 tau 病和α-突触核蛋白病理升高。Exp Neurol 2010; 225: 210-218.
Exp Neurol. 2011 Jan;227(1):13-8. doi: 10.1016/j.expneurol.2010.10.006. Epub 2010 Oct 20.
4
Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease.在病程较长的帕金森病中存在胶质细胞病变,但黑质神经元无凋亡。
Mov Disord. 1998 Mar;13(2):221-7. doi: 10.1002/mds.870130205.
5
Enteric glial cells: new players in Parkinson's disease?肠胶质细胞:帕金森病中的新角色?
Mov Disord. 2015 Apr;30(4):494-8. doi: 10.1002/mds.25979. Epub 2014 Aug 7.
6
Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.大鼠黑质中α-突触核蛋白的过表达导致多巴胺能神经元丧失、α-突触核蛋白磷酸化及半胱天冬酶-9激活:类似于帕金森病的致病变化。
J Neurochem. 2004 Oct;91(2):451-61. doi: 10.1111/j.1471-4159.2004.02728.x.
7
Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.帕金森病和阿尔茨海默病大脑中的α-突触核蛋白病理学:发病率和拓扑分布——一项初步研究。
Acta Neuropathol. 2003 Sep;106(3):191-201. doi: 10.1007/s00401-003-0725-y. Epub 2003 Jul 5.
8
Central role of alpha-synuclein oligomers in neurodegeneration in Parkinson disease.α-突触核蛋白寡聚体在帕金森病神经退行性变中的核心作用
Arch Neurol. 2008 Dec;65(12):1577-81. doi: 10.1001/archneur.65.12.1577.
9
Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.雌激素、神经炎症与帕金森病中的神经保护:神经胶质细胞决定对神经退行性变的抵抗与易感性
Neuroscience. 2006;138(3):869-78. doi: 10.1016/j.neuroscience.2005.07.060. Epub 2005 Dec 5.
10
Glial cells as players in parkinsonism: the "good," the "bad," and the "mysterious" glia.神经胶质细胞在帕金森病中的作用:“有益”、“有害”及“神秘”的胶质细胞
Neuroscientist. 2008 Dec;14(6):544-60. doi: 10.1177/1073858408322839.

引用本文的文献

1
Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy?神经退行性疾病中的去甲肾上腺素能疗法:从对症治疗到疾病修饰治疗?
Brain Commun. 2025 Aug 25;7(5):fcaf310. doi: 10.1093/braincomms/fcaf310. eCollection 2025.
2
Microglial dynamics and neuroinflammation in prodromal and early Parkinson's disease.前驱期及早期帕金森病中的小胶质细胞动态变化与神经炎症
J Neuroinflammation. 2025 May 21;22(1):136. doi: 10.1186/s12974-025-03462-y.
3
Neural-induced human adipose tissue-derived stem cell secretome exerts neuroprotection against rotenone-induced Parkinson's disease in rats.
神经诱导的人脂肪组织来源干细胞分泌组对大鼠鱼藤酮诱导的帕金森病具有神经保护作用。
Stem Cell Res Ther. 2025 Apr 20;16(1):193. doi: 10.1186/s13287-025-04306-5.
4
: a potential trigger of neurodegenerative disease.:神经退行性疾病的一个潜在触发因素。
Front Immunol. 2025 Feb 14;16:1482033. doi: 10.3389/fimmu.2025.1482033. eCollection 2025.
5
Mapping reactive astrogliosis in Parkinson's brain with astroglial tracers BU99008 and Deprenyl: New insights from a multi-marker postmortem study.使用星形胶质细胞示踪剂BU99008和司来吉兰对帕金森病患者大脑中的反应性星形胶质细胞增生进行定位:一项多标记物尸检研究的新见解。
Alzheimers Dement. 2025 Feb;21(2):e14488. doi: 10.1002/alz.14488. Epub 2025 Feb 12.
6
White matter lesions contribute to motor and non-motor disorders in Parkinson's disease: a critical review.白质病变在帕金森病中导致运动和非运动障碍:一项批判性综述。
Geroscience. 2025 Feb;47(1):591-609. doi: 10.1007/s11357-024-01428-1. Epub 2024 Nov 22.
7
The regulation of NFKB1 on CD200R1 expression and their potential roles in Parkinson's disease.NFKB1 对 CD200R1 表达的调控及其在帕金森病中的潜在作用。
J Neuroinflammation. 2024 Sep 18;21(1):229. doi: 10.1186/s12974-024-03231-3.
8
The necessity of eliminating the interference of panaxatriol saponins to maximize the preventive effect of panaxadiol saponins against Parkinson's disease in rats.消除人参三醇皂苷的干扰以最大化人参二醇皂苷对大鼠帕金森病预防作用的必要性。
J Ginseng Res. 2024 Sep;48(5):464-473. doi: 10.1016/j.jgr.2024.05.002. Epub 2024 May 14.
9
The Contribution of Type 2 Diabetes to Parkinson's Disease Aetiology.2型糖尿病对帕金森病病因的影响。
Int J Mol Sci. 2024 Apr 15;25(8):4358. doi: 10.3390/ijms25084358.
10
IPSC-Derived Astrocytes Contribute to In Vitro Modeling of Parkinson's Disease Caused by the N370S Mutation.iPSC 衍生星形胶质细胞有助于体外模拟 N370S 突变引起的帕金森病。
Int J Mol Sci. 2023 Dec 26;25(1):327. doi: 10.3390/ijms25010327.